IRIS
PISATURO, Mariantonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.624
AS - Asia 4.028
NA - Nord America 3.781
SA - Sud America 770
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 19.285
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.495
US - Stati Uniti d'America 3.717
SG - Singapore 1.557
IE - Irlanda 1.291
CN - Cina 769
HK - Hong Kong 765
BR - Brasile 648
DE - Germania 407
IT - Italia 375
UA - Ucraina 316
GB - Regno Unito 286
VN - Vietnam 239
KR - Corea 216
JP - Giappone 150
FI - Finlandia 107
IN - India 105
SE - Svezia 85
TR - Turchia 78
GR - Grecia 77
AR - Argentina 52
FR - Francia 41
AT - Austria 29
BD - Bangladesh 25
CA - Canada 23
PL - Polonia 23
ZA - Sudafrica 23
IQ - Iraq 22
CO - Colombia 17
MX - Messico 16
BE - Belgio 15
PK - Pakistan 15
ID - Indonesia 14
VE - Venezuela 13
EC - Ecuador 12
ES - Italia 11
NL - Olanda 11
MA - Marocco 10
CZ - Repubblica Ceca 9
IR - Iran 9
RS - Serbia 9
PE - Perù 8
AL - Albania 7
LT - Lituania 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
EU - Europa 6
PA - Panama 6
TN - Tunisia 6
UY - Uruguay 6
CL - Cile 5
JM - Giamaica 5
JO - Giordania 5
KE - Kenya 5
PY - Paraguay 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
SN - Senegal 4
BG - Bulgaria 3
CM - Camerun 3
GE - Georgia 3
HN - Honduras 3
IL - Israele 3
LB - Libano 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AU - Australia 2
BB - Barbados 2
BY - Bielorussia 2
CD - Congo 2
CH - Svizzera 2
DK - Danimarca 2
GA - Gabon 2
LV - Lettonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
Totale 19.278
Salva come PNG Salva come JPEG
Città #
Moscow 2.657
Dublin 1.291
Hong Kong 765
Santa Clara 756
Singapore 600
Jacksonville 474
Chandler 438
Seoul 216
Bremen 178
Princeton 176
Ashburn 157
Roxbury 146
Cambridge 119
Hefei 112
Beijing 105
New York 100
Dallas 96
Ho Chi Minh City 91
The Dalles 82
Ann Arbor 73
Bengaluru 70
Caserta 70
Munich 68
São Paulo 62
Medford 58
Boardman 55
Hanoi 54
Wilmington 46
Los Angeles 42
Naples 41
Woodbridge 39
San Mateo 33
Washington 27
Des Moines 26
Nuremberg 22
Helsinki 19
Warsaw 19
Nanjing 18
Brasília 16
Mountain View 16
Rio de Janeiro 16
Brussels 15
Milan 15
Napoli 15
Vienna 15
Da Nang 14
Jinan 13
Johannesburg 13
Tianjin 13
Biên Hòa 12
Düsseldorf 12
Belo Horizonte 11
Curitiba 11
Changsha 10
Porto Alegre 10
Brno 9
Brooklyn 9
Campinas 9
Frankfurt am Main 9
Guangzhou 9
Istanbul 9
Auburn Hills 8
Aversa 8
Chennai 8
Grafing 8
Rome 8
San Francisco 8
Shenyang 8
Tokyo 8
Zhengzhou 8
Haiphong 7
Hangzhou 7
Houston 7
Lappeenranta 7
London 7
Stockholm 7
Tashkent 7
Ariano Irpino 6
Baku 6
Caxias do Sul 6
Chicago 6
Mauá 6
Santo André 6
Shanghai 6
São Bernardo do Campo 6
Tirana 6
Toronto 6
Ankara 5
Baghdad 5
Boston 5
Cairo 5
Criciúma 5
Falkenstein 5
Itajaí 5
Kunming 5
Lucca 5
Maceió 5
Manaus 5
Nairobi 5
Panama City 5
Totale 9.928
Salva come PNG Salva come JPEG
Nome #
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 191
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 188
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 177
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 169
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 164
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 160
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 160
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 159
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 157
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 155
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 153
Absence of occult HCV infection in patients experiencing an immunodepression condition 148
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 147
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 147
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 145
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 142
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 142
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 141
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 137
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 135
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 132
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 131
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 129
Absence of occult HCV infection in HIV-positive patients 128
Clinical and virological characteristics associated with severe acute hepatitis B 127
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 127
ACUTE EXACERBATION OF CHRONIC HEPATITIS C: CLINICAL PRESENTATION, OUTCOME AND RESPONSE TO ANTI-HCV TREATMENT 127
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 125
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 123
F-6 Efficacy and tolerability of peginterferon a-2a and a-2b in patients with chronic hepatitis C by genotype 1: A meta-analysis 122
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 122
Risk and prevention of hepatitis b virus reactivation during immunosuppression for non-oncological diseases 122
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 121
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection 121
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 120
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 120
A HIGH HBSAG GENETIC COMPLEXITY CAN INFLUENCE HBV IMMUNOGENICITY IN THE SETTING OF ACUTE INFECTION 120
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 120
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 115
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 114
Clinical Presentation, Outcomes, and Response to Therapy Among Patients with Acute Exacerbation of Chronic Hepatitis C. 114
Bloodstream Infection Due to a VIM-Metallo-β-Lactamase-Producing Klebsiella pneumoniae Treated with Cefiderocol in a Preterm Newborn 113
Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors 113
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 113
A HIGH GENETIC HETEROGENEITY IN HBsAg CAN AFFECT IMMUNOGENICITY IN ACUTE HEPATITIS B INFECTION 113
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 113
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease 111
P.216 Molecular analysis of genetic variability and epitope stability in a type 1b recurrent HCV infection 111
Absence of occult HCV infection in HIV-positive patients 111
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 109
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data 108
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases. 108
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 108
Role of genetic polymorphisms in hepatitis C virus chronic infection 108
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 108
Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases 108
Epidemiology and management of hepatitis C virus infections in immigrant populations 108
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 107
Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic 107
Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy 107
Occult HBV infection in the oncohematological setting. 107
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 107
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 106
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy 106
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 106
Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. 105
The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. 105
T-14 Virological and clinical impact of anti-HBV nucleos(t)ide analogues in cirrhotic patients with HBV-HCV coinfection 104
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 104
An update on the treatment options for HBV/HCV coinfection 104
Clinical and virological characteristics associated with severe acute hepatitis B 104
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 103
CANNABINOID RECEPTOR 2 (CB2) 63 QQ VARIANT IS ASSOCIATED WITH A SEVERE HISTOLOGICAL ACTIVITY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C 103
A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective, Multicenter Study in Southern Italy 102
Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological Mechanisms 102
Innovative procedures for micro-elimination of HCV infection in persons who use drugs 102
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection 102
Virological factors associated with failure to the latest generation of direct acting agents (Daa) and re-treatment strategy: A narrative review 102
Infezione da HBV in soggetti immigrati: risultati preliminari di uno studio prospettico multicentrico 101
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 100
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 100
HBV molecular epidemiology and clinical condition of immigrants living in Italy 99
Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B 98
Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C 98
Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 98
Role of occult hepatitis B virus infection in chronic hepatitis C 98
Characterization of hepatitis virus co-infections in a cohort of immigrants living in southern Italy 98
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 97
Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings 97
Management of HBV reactivation in non-oncological patients 96
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study 95
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 94
Caratteristiche virologiche e cliniche dell’epatite acuta A in soggetti con infezione cronica da HBV e da HCV. 94
Role of occult hepatitis B virus infection in chronic hepatitis C 94
Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment 94
The association between education level and chronic liver disease of any etiology 94
Clinical impact of occult hepatitis B virus infection in immunosuppressed patients 94
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 94
Early predictors of clinical deterioration in a cohort of outpatients with COVID-19 in southern Italy: A multicenter observational study 93
RITUXIMAB-BASED TREATMENT, HCV REPLICATION AND HEPATIC FLARES 93
Totale 11.774
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021419 0 0 0 0 0 18 92 79 17 109 88 16
2021/2022913 35 15 2 8 210 13 104 11 23 83 66 343
2022/20232.137 193 56 27 115 299 127 2 102 1.126 15 37 38
2023/2024985 68 23 73 68 350 116 15 26 10 11 48 177
2024/20253.185 9 39 14 86 480 442 395 302 537 460 236 185
2025/202610.530 508 601 655 613 1.094 7.059 0 0 0 0 0 0
Totale 19.605